Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graft-versus-host Disease Prevention”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03192397
What this trial is testing

Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Who this might be right for
Acute Myeloid Leukemia in RemissionAdult Acute Lymphoblastic Leukemia in Complete RemissionChronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission+10 more
Roswell Park Cancer Institute 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT06098313
What this trial is testing

HCT With PTCy in Higher-risk MDS

Who this might be right for
Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
Asan Medical Center 113
Early research (Phase 1)Looking for participantsNCT04886726
What this trial is testing

PTCY Plus uhCG/EGF for Graft Versus Host Disease Prophylaxis

Who this might be right for
Graft Versus Host Disease
Henry Ford Health System 18
Testing effectiveness (Phase 2)Study completedNCT01283776
What this trial is testing

Cyclophosphamide as Sole Graft-Versus-Host-Prophylaxis After Allogeneic Stem Cell Transplantation

Who this might be right for
Multiple MyelomaNon-Hodgkin-LymphomaHodgkin's Disease
University of Cologne 11
Large-scale testing (Phase 3)Study completedNCT01951885
What this trial is testing

Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention

Who this might be right for
Chronic Myelogenous LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+7 more
Case Comprehensive Cancer Center 101
Testing effectiveness (Phase 2)Study completedNCT03339297
What this trial is testing

An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD)

Who this might be right for
Graft-versus-host DiseaseAcute-graft-versus-host Disease
Jazz Pharmaceuticals 152
Testing effectiveness (Phase 2)Ended earlyNCT02877082
What this trial is testing

Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients

Who this might be right for
Acute LeukemiaChronic Lymphocytic LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+9 more
Emory University 5
Testing effectiveness (Phase 2)Looking for participantsNCT06199427
What this trial is testing

PTCy and and Ruxolitinib for GVHD Prophylaxis After HSCT With Thymoglobulin in Conditioning Regimen in Patients With Inborn Errors of Immunity

Who this might be right for
Inborn Errors of Immunity
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 100
Large-scale testing (Phase 3)Study completedNCT00210860
What this trial is testing

An Open Label Extension of a Study Comparing Topiramate and Amitriptyline in Migraine Prevention.

Who this might be right for
Migraine
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 142
Testing effectiveness (Phase 2)Study completedNCT00346359
What this trial is testing

Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+2 more
Fred Hutchinson Cancer Center 40
Large-scale testing (Phase 3)Looking for participantsNCT02416388
What this trial is testing

Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR

Who this might be right for
Acute Myeloid Leukemia (AML)
University Hospital, Angers 3,100
Testing effectiveness (Phase 2)Ended earlyNCT01044745
What this trial is testing

Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+108 more
University of Nebraska 20
Large-scale testing (Phase 3)Study completedNCT00210912
What this trial is testing

The Effectiveness and Safety of Topiramate Versus Placebo for Preventing Chronic Migraine Headaches

Who this might be right for
Migraine
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 328
Not applicableStudy completedNCT00003538
What this trial is testing

Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableEnded earlyNCT03102060
What this trial is testing

Gluten Free Diet in Preventing Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
Graft Versus Host DiseaseHematopoietic Cell Transplantation Recipient
Rutgers, The State University of New Jersey 7
Testing effectiveness (Phase 2)Ended earlyNCT00548717
What this trial is testing

Sirolimus, Mycophenolate Mofetil and Bortezomib as Graft-Versus-Host Disease (GVHD) Prophylaxis After Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplantation

Who this might be right for
Graft-vs-Host Disease
Dana-Farber Cancer Institute 15
Post-approval studies (Phase 4)Looking for participantsNCT07029958
What this trial is testing

Improved Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Protocol for the Treatment of Epstein Barr Virus T/NK Lymphoproliferative Disease (EBV-T/NK LPD) and Prevention of Post Transplant Graft-versus-host Disease

Who this might be right for
EBV-T/NK LPD
Beijing Children's Hospital 48
Testing effectiveness (Phase 2)Study completedNCT01323920
What this trial is testing

Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndrome
Dana-Farber Cancer Institute 35
Large-scale testing (Phase 3)Ended earlyNCT03805789
What this trial is testing

The Safety and Efficacy of Alpha-1 Antitrypsin (AAT) for the Prevention of Graft-versus-host Disease (GVHD) in Patients Receiving Hematopoietic Cell Transplant

Who this might be right for
Acute-graft-versus-host Disease
CSL Behring 222
Testing effectiveness (Phase 2)Looking for participantsNCT04380740
What this trial is testing

Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis

Who this might be right for
Graft Vs Host Disease
Boston Children's Hospital 160
Next Page